Literature DB >> 22236696

Replenishing B lymphocytes in health and disease.

Qingzhao Zhang1, Ryuji Iida, Tomoyuki Shimazu, Paul W Kincade.   

Abstract

The path from hematopoietic stem cells (HSCs) to functional B lymphocytes has long been appreciated as a basic model of differentiation, but much clinically relevant information has also been obtained. It is now possible to conduct single cell studies with increasingly high resolution, revealing that individual stem and progenitor cells differ from each other with respect to differentiation potential and fates. B lymphopoiesis is now seen as a gradual and unsynchronized process where progenitors eventually become B lineage restricted. Major milestones have been identified, but a precise sequence need not be followed and oscillation between states is possible. It is not yet clear if this versatility has survival value, but information is accumulating about infections and age-related changes.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22236696      PMCID: PMC3570822          DOI: 10.1016/j.coi.2011.12.007

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  61 in total

1.  Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment.

Authors:  Toshihiro Miyamoto; Hiromi Iwasaki; Boris Reizis; Min Ye; Thomas Graf; Irving L Weissman; Koichi Akashi
Journal:  Dev Cell       Date:  2002-07       Impact factor: 12.270

2.  Adult T-cell progenitors retain myeloid potential.

Authors:  Haruka Wada; Kyoko Masuda; Rumi Satoh; Kiyokazu Kakugawa; Tomokatsu Ikawa; Yoshimoto Katsura; Hiroshi Kawamoto
Journal:  Nature       Date:  2008-04-10       Impact factor: 49.962

3.  A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells.

Authors:  Rebecca H Cho; Hans B Sieburg; Christa E Muller-Sieburg
Journal:  Blood       Date:  2008-04-15       Impact factor: 22.113

Review 4.  Modulation of bone marrow stromal cell functions in infectious diseases by toll-like receptor ligands.

Authors:  Krisztian Nemeth; Balazs Mayer; Eva Mezey
Journal:  J Mol Med (Berl)       Date:  2009-09-13       Impact factor: 4.599

5.  Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age.

Authors:  Wendy W Pang; Elizabeth A Price; Debashis Sahoo; Isabel Beerman; William J Maloney; Derrick J Rossi; Stanley L Schrier; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

6.  Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation.

Authors:  Richard C Allsopp; Gregg B Morin; Ronald DePinho; Calvin B Harley; Irving L Weissman
Journal:  Blood       Date:  2003-03-27       Impact factor: 22.113

7.  Contrasting responses of lymphoid progenitors to canonical and noncanonical Wnt signals.

Authors:  Sachin Malhotra; Yoshihiro Baba; Karla P Garrett; Frank J T Staal; Rachel Gerstein; Paul W Kincade
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

8.  Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells.

Authors:  Brad Dykstra; Sandra Olthof; Jaring Schreuder; Martha Ritsema; Gerald de Haan
Journal:  J Exp Med       Date:  2011-11-21       Impact factor: 14.307

9.  Candida albicans induces selective development of macrophages and monocyte derived dendritic cells by a TLR2 dependent signalling.

Authors:  Alberto Yáñez; Javier Megías; José-Enrique O'Connor; Daniel Gozalbo; M Luisa Gil
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

10.  A novel assay to trace proliferation history in vivo reveals that enhanced divisional kinetics accompany loss of hematopoietic stem cell self-renewal.

Authors:  Jens M Nygren; David Bryder
Journal:  PLoS One       Date:  2008-11-12       Impact factor: 3.240

View more
  6 in total

1.  RAG-1 and Ly6D independently reflect progression in the B lymphoid lineage.

Authors:  Qingzhao Zhang; Brandt L Esplin; Ryuji Iida; Karla P Garrett; Zhixin L Huang; Kay L Medina; Paul W Kincade
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

Review 2.  Complementary regulation of early B-lymphoid differentiation by genetic and epigenetic mechanisms.

Authors:  Takafumi Yokota; Takao Sudo; Tomohiko Ishibashi; Yukiko Doi; Michiko Ichii; Kenji Orirani; Yuzuru Kanakura
Journal:  Int J Hematol       Date:  2013-09-03       Impact factor: 2.490

3.  Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responses.

Authors:  Diego A Vargas-Inchaustegui; Iskra Tuero; Venkatramanan Mohanram; Thomas Musich; Poonam Pegu; Antonio Valentin; Yongjun Sui; Margherita Rosati; Jenifer Bear; David J Venzon; Viraj Kulkarni; Candido Alicea; Guy R Pilkington; Namal P M Liyanage; Thorsten Demberg; Shari N Gordon; Yichuan Wang; Alison E Hogg; Blake Frey; L Jean Patterson; Janet DiPasquale; David C Montefiori; Niranjan Y Sardesai; Steven G Reed; Jay A Berzofsky; Genoveffa Franchini; Barbara K Felber; George N Pavlakis; Marjorie Robert-Guroff
Journal:  Clin Immunol       Date:  2014-06-04       Impact factor: 3.969

Review 4.  Mesenchymal Stem Cell Immunomodulation: A Novel Intervention Mechanism in Cardiovascular Disease.

Authors:  Yueyao Wang; Zhongwen Qi; Zhipeng Yan; Nan Ji; Xiaoya Yang; Dongjie Gao; Leilei Hu; Hao Lv; Junping Zhang; Meng Li
Journal:  Front Cell Dev Biol       Date:  2022-01-12

Review 5.  Early events in lymphopoiesis: an update.

Authors:  Qingzhao Zhang; Ryuji Iida; Takafumi Yokota; Paul W Kincade
Journal:  Curr Opin Hematol       Date:  2013-07       Impact factor: 3.284

6.  The transcriptional architecture of early human hematopoiesis identifies multilevel control of lymphoid commitment.

Authors:  Elisa Laurenti; Sergei Doulatov; Sasan Zandi; Ian Plumb; Jing Chen; Craig April; Jian-Bing Fan; John E Dick
Journal:  Nat Immunol       Date:  2013-05-26       Impact factor: 25.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.